What does CUSIP 87650L103 represent in this 13F holders report?

CUSIP 87650L103 is the security identifier for TARS - Tarsus Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in Q1 2023?

73 institutional investors reported TARS - Tarsus Pharmaceuticals, Inc. - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)

CUSIP: 87650L103

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock
Total 13F shares: 20,057,814
Total 13F value: $252,130,256
Share change: -473,237
Put/Call ratio: 480%
SEC-reported price per share: $12.57
Number of holders: 73
Value change: -$6,023,437
Number of buys: 37
Number of sells: 24
Shares outstanding: 43,212,246

Security key

87650L103

Report period

Q1 2023

Institutions

Top holders

TARS full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Tarsus Pharmaceuticals, Inc. SEC filings Tarsus Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 87650L103

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Vivo Capital IX, LLC

Disclosed value leader

Vivo Capital IX, LLC

Comparable rows

0/15

Latest evidence

31 Dec 2022

3/4/5 13F Highest disclosed value: $49,380,020 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Vivo Capital IX, LLC has the largest disclosed position value at $49.38M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Capital IX, LLC's linked filing trail.

Disclosed position value Top 5

Vivo Capital IX, LLC $49.38M

RTW INVESTMENTS, LP $40.27M

Jason E. Tester $109.9K

Vivo Capital, LLC $33.16M

TANG CAPITAL MANAGEMENT LLC $29.34M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Vivo Capital IX, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$49,380,020 2,469,001 shares	—	05 May 2022
RTW INVESTMENTS, LP	3/4/5 13F 10%+ Owner · Company 3/4/5 13F	— denominator unverified	$40,272,020 2,013,601 shares	—	07 May 2021
Jason E. Tester	3/4/5 Director, 10%+ Owner 3/4/5	— denominator unverified	$109,900 10,000 shares	—	15 Jun 2021
Vivo Capital, LLC	13F Company 13F	— denominator unverified	$33,164,000 2,262,200 shares	—	31 Dec 2022
TANG CAPITAL MANAGEMENT LLC	13F Company 13F	— denominator unverified	$29,343,236 2,001,585 shares	—	31 Dec 2022
Frazier Life Sciences Management, L.P.	13F Company 13F	— denominator unverified	$26,205,146 1,787,527 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

20,057,814

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend